WHO ICTRP trial
Clinical trial for examination of efficacy and safety of ANGOCIN® Anti-Infekt N…
EUCTR2013-004653-25-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-004653-25-DE |
|---|---|
| Public title | Clinical trial for examination of efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in the continous prophylaxis of chronically recurring uncomplicated cystitis |
| Scientific title | Clinical trial for examination of efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in the continous prophylaxis of chronically recurring uncomplicated cystitis - ANGOPROH |
| Primary sponsor | Repha GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Continuous prophylaxis of chronically recurring uncomplicated cystitis MedDRA version: 20.1 Level: LLT Classification code 10011786 Term: Cystitis chronic System Organ Class: 100000004862 MedDRA version: 21.1 Level: PT Classification code… |
| Interventions | Trade Name: Angocin Anti-Infekt N Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Horseradish root powder Other descriptive name: Meerrettichwurzelpulver Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Feb 25, 2014 |
| Target size | 224 |
| Secondary IDs | Repha_1362 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: